Leendert Staal Quotations

There is nobody who can, with any certainty, forecast demand. But there is definitely not a need for increased capacity for custom manufacturing. Speculative investment of several hundred million dollars is not the wisest move.

Our priority now, our aim, is to get 25% market share.

The protein market is growing rapidly and may reach $200 billion in 15 to 20 years, and we believe that PER.C6 has the potential to become the technology of choice for an attractive part of that market.

We see the potential for a production vehicle with tremendous flexibility, which is a real alternative to Chinese hamster ovaries, the current industry standard. We have set ourselves a target of 25% of all new proteins and monoclonal antibodies. For anything in development and reaching the market between 2015 and 2020, we want 25% of the production platform to be PER.C6.